In the first study to compare transcatheter aortic valve replacement or implantation to surgical aortic valve replacement ...

Asia Pacific is the fastest growing region for health care spending, and by 2030 APAC will account for more than 20% of ...

Seoul, South Korea-based Neudive Inc. is advancing a game-like digital therapeutic called Buddy-in as a software solution for ...

Nextpoint Therapeutics Inc. has unveiled NPX-372, a novel T-cell engager for solid tumors. NPX-372 is a CD3 bispecific ...

Immortality and eternal youth have been the stuff of myths and legends from ancient times on. Now, in the 21st century, real ...

In what represents Vienna, Austria-based Valeriot GmbH’s first patenting, its founder and CEO, Michael Flatscher, describes ...

John Collings was running a medtech business in China, he was flying high with multiple rounds of investment under his belt ...

Vivet Therapeutics SAS has announced its gene therapy VTX-806 has been awarded European orphan drug designation for the ...

Biopharma IPOs have faced tough conditions in recent years, but 2024 is showing signs of improvement in terms of value, while ...

Elixir Medical Corp. reported positive 12-month data from the Infinity-Swedeheart trial that compared its Dynamx coronary ...

Cytokinetics Inc. CEO Robert Blum said his firm chalked “a watershed moment” during last weekend’s congress of European ...

Litigation between companies in the med-tech space often revolves around patents, but the ongoing series of lawsuits between ...